Form 8-K - Current report:
SEC Accession No. 0001625297-25-000059
Filing Date
2025-08-26
Accepted
2025-08-26 07:45:34
Documents
12
Period of Report
2025-08-26
Items
Item 2.05: Cost Associated with Exit or Disposal Activities

Document Format Files

Seq Description Document Type Size
1 8-K indv-20250826.htm   iXBRL 8-K 32343
  Complete submission text file 0001625297-25-000059.txt   143806

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT indv-20250826.xsd EX-101.SCH 1773
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT indv-20250826_lab.xml EX-101.LAB 21615
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT indv-20250826_pre.xml EX-101.PRE 12502
14 EXTRACTED XBRL INSTANCE DOCUMENT indv-20250826_htm.xml XML 2448
Mailing Address 234 BATH ROAD SLOUGH, BERKSHIRE X0 SL1 4EE
Business Address 234 BATH ROAD SLOUGH, BERKSHIRE X0 SL1 4EE 804-379-1090
INDIVIOR PLC (Filer) CIK: 0001625297 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37835 | Film No.: 251252630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)